Yuki Hayashi

1.1k total citations
30 papers, 800 citations indexed

About

Yuki Hayashi is a scholar working on Oncology, Epidemiology and Genetics. According to data from OpenAlex, Yuki Hayashi has authored 30 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Epidemiology and 7 papers in Genetics. Recurrent topics in Yuki Hayashi's work include Inflammatory Bowel Disease (7 papers), Antibiotic Use and Resistance (3 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). Yuki Hayashi is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Antibiotic Use and Resistance (3 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). Yuki Hayashi collaborates with scholars based in Japan, Australia and United States. Yuki Hayashi's co-authors include David L. Paterson, Hiroshi Nakase, Yoshihiro Yokoyama, Benjamin A. Rogers, Zohreh Aminzadeh, Tadashi Ichimiya, Daisuke Hirayama, Tsukasa Yamakawa, Kohei Wagatsuma and Takehiro Hirano and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Yuki Hayashi

30 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Hayashi Japan 13 265 200 136 125 97 30 800
Lei Tian China 17 175 0.7× 199 1.0× 181 1.3× 98 0.8× 91 0.9× 51 1.1k
Giorgia Montrucchio Italy 18 273 1.0× 157 0.8× 78 0.6× 96 0.8× 153 1.6× 61 994
Francesco Sbrana Italy 16 196 0.7× 102 0.5× 156 1.1× 80 0.6× 266 2.7× 92 823
Pablo Vidal Spain 13 152 0.6× 84 0.4× 59 0.4× 58 0.5× 49 0.5× 55 622
John L. Clark United States 10 81 0.3× 105 0.5× 154 1.1× 53 0.4× 80 0.8× 23 595
Kunihiko Kooguchi Japan 7 171 0.6× 263 1.3× 184 1.4× 40 0.3× 96 1.0× 22 941
Zhitao Yang China 21 359 1.4× 295 1.5× 71 0.5× 43 0.3× 111 1.1× 83 1.2k
Canmao Xie China 21 228 0.9× 290 1.4× 154 1.1× 39 0.3× 178 1.8× 78 1.3k
Maria Raftogiannis Greece 16 400 1.5× 105 0.5× 76 0.6× 26 0.2× 53 0.5× 27 684
Peter Matzneller Austria 17 193 0.7× 144 0.7× 131 1.0× 24 0.2× 77 0.8× 49 898

Countries citing papers authored by Yuki Hayashi

Since Specialization
Citations

This map shows the geographic impact of Yuki Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Hayashi more than expected).

Fields of papers citing papers by Yuki Hayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Hayashi. The network helps show where Yuki Hayashi may publish in the future.

Co-authorship network of co-authors of Yuki Hayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Hayashi. A scholar is included among the top collaborators of Yuki Hayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Hayashi. Yuki Hayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yokoyama, Yoshihiro, et al.. (2025). Unraveling the complexity of ulcerative colitis: insights into cytokine dysregulation and targeted therapies. PubMed. 24. 638–658. 1 indexed citations
2.
Kurumi, Hiroki, Yoshihiro Yokoyama, Takehiro Hirano, et al.. (2024). Cytokine Profile in Predicting the Effectiveness of Advanced Therapy for Ulcerative Colitis: A Narrative Review. Biomedicines. 12(5). 952–952. 8 indexed citations
3.
Ichimiya, Tadashi, Keisuke Ishigami, Yoshihiro Yokoyama, et al.. (2023). Application of plasma alternative to serum for measuring leucine-rich α2-glycoprotein as a biomarker of inflammatory bowel disease. PLoS ONE. 18(6). e0286415–e0286415. 4 indexed citations
4.
Hayashi, Yuki & Hiroshi Nakase. (2022). The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn’s Disease. Frontiers in Physiology. 13. 845078–845078. 28 indexed citations
5.
Hayashi, Yuki, Kohei Wagatsuma, Masanori Nojima, et al.. (2021). The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis. Journal of Gastroenterology. 56(5). 409–420. 27 indexed citations
6.
Ichimiya, Tadashi, Tsukasa Yamakawa, Takehiro Hirano, et al.. (2020). Autophagy and Autophagy-Related Diseases: A Review. International Journal of Molecular Sciences. 21(23). 8974–8974. 233 indexed citations
7.
Nakase, Hiroshi, Takehiro Hirano, Kohei Wagatsuma, et al.. (2020). Artificial intelligence‐assisted endoscopy changes the definition of mucosal healing in ulcerative colitis. Digestive Endoscopy. 33(6). 903–911. 24 indexed citations
8.
Roberts, Jason A., Andrew Udy, Jürgen B. Bulitta, et al.. (2014). Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration. Journal of Antimicrobial Chemotherapy. 69(9). 2508–2516. 23 indexed citations
9.
Rogers, Benjamin A., Zohreh Aminzadeh, Yuki Hayashi, & David L. Paterson. (2011). Country-to-Country Transfer of Patients and the Risk of Multi-Resistant Bacterial Infection. Clinical Infectious Diseases. 53(1). 49–56. 133 indexed citations
10.
Hayashi, Yuki & David L. Paterson. (2011). Strategies for Reduction in Duration of Antibiotic Use in Hospitalized Patients. Clinical Infectious Diseases. 52(10). 1232–1240. 107 indexed citations
11.
12.
Baba, Hisashi, Graeme R. Nimmo, Anthony Allworth, et al.. (2011). The role of surveillance cultures in the prediction of susceptibility patterns of Gram-negative bacilli in the intensive care unit. European Journal of Clinical Microbiology & Infectious Diseases. 30(6). 739–744. 14 indexed citations
13.
Wakayama, Teruhiko, Yuki Hayashi, & Atsuo Ogura. (1997). Participation of the female pronucleus derived from the second polar body in full embryonic development of mice. Reproduction. 110(2). 263–266. 46 indexed citations
14.
Higashiyama, Hiroki, Isao Saito, Yuki Hayashi, & N. Miyasaka. (1995). In situ hybridization study of vascular cell adhesion molecule-1 messenger RNA expression in rheumatoid synovium. Journal of Autoimmunity. 8(6). 947–957. 4 indexed citations
15.
Shimizu, Junzo, Yusuke Watanabe, Masako Oda, et al.. (1993). [Results of surgical treatment of stage I lung cancer].. PubMed. 94(5). 505–10. 19 indexed citations
16.
Hoon, Dave S.�B., T. Morisaki, Akihiko Uchiyama, et al.. (1993). Augmentation of T‐Cell Response with a Melanoma Cell Vaccine Expressing Specific HLA‐A Antigens. Annals of the New York Academy of Sciences. 690(1). 343–345. 3 indexed citations
17.
Murakami, Shinya, Hajime Satō, Norihiko Ishikawa, et al.. (1993). Tracheal Reconstruction after Lower Tracheal Resection Using the Inverted Right Bronchus - an Experimental Study. The Thoracic and Cardiovascular Surgeon. 41(6). 335–339. 4 indexed citations
18.
Takeuchi, Motoshi, Michio Odake, Hideyuki Takaoka, Yuki Hayashi, & M Yokoyama. (1992). Comparison between preload recruitable stroke work and the end-systolic pressure-volume relationship in man. European Heart Journal. 13(suppl E). 80–84. 46 indexed citations
19.
Watanabe, Yusuke, Junya Shimizu, Naoki Murakami, et al.. (1988). [The role of surgery in the management of small cell carcinoma of the lung].. PubMed. 41(3). 178–83. 1 indexed citations
20.
Hayashi, Yuki, et al.. (1980). [Comparison of treatments in senile osteoporosis: follow up for 12 months (author's transl)].. PubMed. 54(4). 345–55. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026